Sanofi may seek US approval for Dengvaxia despite Philippines outrage
PARIS, March 7 (Reuters) – Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains committed to the medicine despite a health scare in the Philippines, a senior executiveRead more
Subic-Blog